169 related articles for article (PubMed ID: 19740430)
1. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.
Chen B; Cao S; Zhang Y; Wang X; Liu J; Hui X; Wan Y; Du W; Wang L; Wu K; Fan D
BMC Cell Biol; 2009 Sep; 10():63. PubMed ID: 19740430
[TBL] [Abstract][Full Text] [Related]
2. GX1 targeting delivery of rmhTNFα evaluated using multimodality imaging.
Hu H; Yin J; Wang M; Liang C; Song H; Wang J; Nie Y; Liang J; Wu K
Int J Pharm; 2014 Jan; 461(1-2):181-91. PubMed ID: 24269209
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC.
Hui X; Han Y; Liang S; Liu Z; Liu J; Hong L; Zhao L; He L; Cao S; Chen B; Yan K; Jin B; Chai N; Wang J; Wu K; Fan D
J Control Release; 2008 Oct; 131(2):86-93. PubMed ID: 18700158
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and characterization of recombinant protein GX1-rmhTNFalpha.
Cao S; Liu Y; Li X; Zhang Y; Wang J; Du W; Han Y; Jin H; Zhao L; Wu K; Fan D
Mol Biotechnol; 2009 Sep; 43(1):1-7. PubMed ID: 19357993
[TBL] [Abstract][Full Text] [Related]
5. [Cloning, expression and identification of recombinant fusion protein GX1-rmhTNFalpha].
Cao SS; Wu KC; Yan Z; Wan Y; Han Y; Zhao LN; Fan DM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):360-2. PubMed ID: 16643800
[TBL] [Abstract][Full Text] [Related]
6. Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer.
Lei Z; Chai N; Tian M; Zhang Y; Wang G; Liu J; Tian Z; Yi X; Chen D; Li X; Yu P; Hu H; Xu B; Jian C; Bian Z; Guo H; Wang J; Peng S; Nie Y; Huang N; Hu S; Wu K
Cell Death Dis; 2018 May; 9(6):579. PubMed ID: 29785022
[TBL] [Abstract][Full Text] [Related]
7.
Yin J; Xin B; Hui X; Chai N; Yao L; Hu H; Xu B; Ma W; Zhang M; Wang J; Nie Y; Zhou G; Wang G; Chen L; Lu H; Wu K
Eur J Pharm Biopharm; 2020 Sep; 154():144-152. PubMed ID: 32682942
[TBL] [Abstract][Full Text] [Related]
8. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
[TBL] [Abstract][Full Text] [Related]
9. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
[TBL] [Abstract][Full Text] [Related]
10. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
[TBL] [Abstract][Full Text] [Related]
11. GX1-mediated anionic liposomes carrying adenoviral vectors for enhanced inhibition of gastric cancer vascular endothelial cells.
Xiong D; Liu Z; Bian T; Li J; Huang W; Jing P; Liu L; Wang Y; Zhong Z
Int J Pharm; 2015 Dec; 496(2):699-708. PubMed ID: 26570987
[TBL] [Abstract][Full Text] [Related]
12. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
[TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.
Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M
Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514
[TBL] [Abstract][Full Text] [Related]
15. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
[TBL] [Abstract][Full Text] [Related]
16. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model.
Wu H; Xin Y; Zhao J; Sun D; Li W; Hu Y; Wang S
Cancer Chemother Pharmacol; 2011 Oct; 68(4):879-87. PubMed ID: 21290245
[TBL] [Abstract][Full Text] [Related]
17. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
18. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
19. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
Yan S; Zhang H; Xie Y; Sheng W; Xiang J; Ye Z; Chen W; Yang J
Cancer Invest; 2010 Jan; 28(1):85-93. PubMed ID: 19916746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
